Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction

[1] Peet C(2020)Cardiac monocytes and macrophages after myocardial infarction Cardiovasc Res 116 1101-1112

[2] Ivetic A(2017)Acute myocardial infarction Lancet 389 197-210

[3] Bromage DI(2008)Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 2057-2062

[4] Shah AM(2012)2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis Arthritis Care Res (Hoboken) 64 1447-1461

[5] Reed GW(2016)EULAR recommendations for the management of familial Mediterranean fever Ann Rheum Dis 75 644-651

[6] Rossi JE(2015)2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 36 2921-2964

[7] Cannon CP(2019)Management of skin, mucosa and joint involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome Semin Arthritis Rheum 48 752-762

[8] Velagaleti RS(2020)Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT) Eur Heart J 41 4092-4099

[9] Pencina MJ(2019)Efficacy and safety of low-dose colchicine after myocardial infarction N Engl J Med 381 2497-2505

[10] Murabito JM(2017)Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model Int J Cardiol 240 347-353

[1] Peet C(2020)Cardiac monocytes and macrophages after myocardial infarction Cardiovasc Res 116 1101-1112

[2] Ivetic A(2017)Acute myocardial infarction Lancet 389 197-210

[3] Bromage DI(2008)Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 2057-2062

[4] Shah AM(2012)2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis Arthritis Care Res (Hoboken) 64 1447-1461

[5] Reed GW(2016)EULAR recommendations for the management of familial Mediterranean fever Ann Rheum Dis 75 644-651

[6] Rossi JE(2015)2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 36 2921-2964

[7] Cannon CP(2019)Management of skin, mucosa and joint involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome Semin Arthritis Rheum 48 752-762

[8] Velagaleti RS(2020)Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT) Eur Heart J 41 4092-4099

[9] Pencina MJ(2019)Efficacy and safety of low-dose colchicine after myocardial infarction N Engl J Med 381 2497-2505

[10] Murabito JM(2017)Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model Int J Cardiol 240 347-353